FDA Approves Faricimab for nAMD and Diabetic Macular Edema FDA Approves Faricimab for nAMD and Diabetic Macular Edema

The FDA has approved faricimab, a drug with the potential to reduce the number of injections needed to treat diabetic macular edema and neovascular age-related macular degeneration.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news